No Data
No Data
No Data
No Data
No Data
Rezolute to Present Phase 2 RIZE Study at PES Meeting
TipRanksApr 26 05:32
Phase 2 RIZE Study Sub-Analyses To Be Presented At 2024 Pediatric Endocrine Society Annual Meeting
Phase 2 RIZE Study Sub-Analyses To Be Presented At 2024 Pediatric Endocrine Society Annual Meeting
BenzingaApr 23 20:12
J.P. Morgan Securities: Rezolute (RZLT.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $7.00.
J.P. Morgan Securities: Rezolute (RZLT.US) rating was reaffirmed and adjusted from superior to superior market rating, with a target price of $7.00.
Zhitong FinanceApr 20 00:30
JMP Securities Reiterates Market Outperform on Rezolute, Maintains $7 Price Target
JMP Securities analyst Jason Butler reiterates Rezolute (NASDAQ:RZLT) with a Market Outperform and maintains $7 price target.
BenzingaApr 19 01:34
Rezolute Initiated at Buy by JonesTrading
Rezolute Initiated at Buy by JonesTrading
Dow JonesApr 18 20:20
JonesTrading Initiates Coverage On Rezolute With Buy Rating, Announces Price Target of $10
JonesTrading analyst Catherine Novack initiates coverage on Rezolute with a Buy rating and announces Price Target of $10.
Analyst UpgradesApr 18 20:10
No Data
No Data